FLT3 is expressed on the cell surface of AML blasts and approximately one-third of AML patients carry internal tandem duplications (ITDs) in the FLT3 gene, which are associated with a poor prognosis [72]. This evidence concerns the gene FLT3 and acute myeloid leukemia.